0.60Open0.92Pre Close33 Volume3.57K Open Interest80.00Strike Price1.56KTurnover40.77%IV0.58%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.4593Delta0.6142Gamma398.95Leverage Ratio-0.9210Theta0.0001Rho183.25Eff Leverage0.0063Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet